Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 871

1.

Comorbidity Analysis between Alzheimer's Disease and Type 2 Diabetes Mellitus (T2DM) Based on Shared Pathways and the Role of T2DM Drugs.

Karki R, Tom Kodamullil A, Hofmann-Apitius M.

J Alzheimers Dis. 2017 Sep 8. doi: 10.3233/JAD-170440. [Epub ahead of print]

PMID:
28922161
2.

Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.

Zhou XL, Xue WH, Ding XF, Li LF, Dou MM, Zhang WJ, Lv Z, Fan ZR, Zhao J, Wang LX.

Oncotarget. 2017 Apr 8;8(33):55622-55631. doi: 10.18632/oncotarget.16973. eCollection 2017 Aug 15. Review.

PMID:
28903449
3.

Effects of metformin on survival outcomes of pancreatic cancer: a meta-analysis.

Dong YW, Shi YQ, He LW, Cui XY, Su PZ.

Oncotarget. 2017 May 26;8(33):55478-55488. doi: 10.18632/oncotarget.18233. eCollection 2017 Aug 15.

PMID:
28903435
4.

The Clinical Effect of Metformin on the Survival of Lung Cancer Patients with Diabetes: A Comprehensive Systematic Review and Meta-analysis of Retrospective Studies.

Cao X, Wen ZS, Wang XD, Li Y, Liu KY, Wang X.

J Cancer. 2017 Aug 2;8(13):2532-2541. doi: 10.7150/jca.19750. eCollection 2017.

5.

[Which antidiabetic agent in a patient with type 2 diabetes and heart failure ?]

Scheen AJ, Paquot N.

Rev Med Liege. 2017 Sep;72(9):423-428. French.

PMID:
28892319
6.

Network meta-analysis of lorcaserin and oral hypoglycaemics for patients with type 2 diabetes mellitus and obesity.

Neff LM, Broder MS, Beenhouwer D, Chang E, Papoyan E, Wang ZW.

Clin Obes. 2017 Sep 10. doi: 10.1111/cob.12213. [Epub ahead of print]

PMID:
28891142
8.

Dapagliflozin/Saxagliptin Fixed-Dose Tablets: A New Sodium-Glucose Cotransporter 2 and Dipeptidyl Peptidase 4 Combination for the Treatment of Type 2 Diabetes.

Coppenrath VA, Hydery T.

Ann Pharmacother. 2017 Sep 1:1060028017731111. doi: 10.1177/1060028017731111. [Epub ahead of print]

PMID:
28884600
9.

Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies.

Nielsen SM, Bartels EM, Henriksen M, Wæhrens EE, Gudbergsen H, Bliddal H, Astrup A, Knop FK, Carmona L, Taylor WJ, Singh JA, Perez-Ruiz F, Kristensen LE, Christensen R.

Ann Rheum Dis. 2017 Sep 2. pii: annrheumdis-2017-211472. doi: 10.1136/annrheumdis-2017-211472. [Epub ahead of print]

10.

Optimizing the Treatment of Steroid-Induced Hyperglycemia.

Wallace MD, Metzger NL.

Ann Pharmacother. 2017 Aug 1:1060028017728297. doi: 10.1177/1060028017728297. [Epub ahead of print]

PMID:
28836444
11.

A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction.

Hesen NA, Riksen NP, Aalders B, Ritskes-Hoitinga M, El Messaoudi S, Wever KE.

PLoS One. 2017 Aug 23;12(8):e0183664. doi: 10.1371/journal.pone.0183664. eCollection 2017.

12.

Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis.

Wu S, Chai S, Yang J, Cai T, Xu Y, Yang Z, Zhang Y, Ji L, Sun F, Zhan S.

Clin Ther. 2017 Sep;39(9):1780-1789.e33. doi: 10.1016/j.clinthera.2017.07.036. Epub 2017 Aug 18.

PMID:
28827024
13.

Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.

Campbell JM, Bellman SM, Stephenson MD, Lisy K.

Ageing Res Rev. 2017 Aug 10;40:31-44. doi: 10.1016/j.arr.2017.08.003. [Epub ahead of print] Review.

PMID:
28802803
14.

Metformin and Alzheimer's disease, dementia and cognitive impairment: a systematic review protocol.

Campbell JM, Stephenson MD, de Courten B, Chapman I, Bellman SM, Aromataris E.

JBI Database System Rev Implement Rep. 2017 Aug;15(8):2055-2059. doi: 10.11124/JBISRIR-2017-003380.

PMID:
28800055
15.

Systematic review of metformin monotherapy and dual therapy with sodium glucose co-transporter 2 inhibitor (SGLT-2) in treatment of type 2 diabetes mellitus.

Molugulu N, Yee LS, Ye YT, Khee TC, Nie LZ, Yee NJ, Yee TK, Liang TC, Kesharwani P.

Diabetes Res Clin Pract. 2017 Jul 25. pii: S0168-8227(17)30827-6. doi: 10.1016/j.diabres.2017.07.025. [Epub ahead of print]

PMID:
28797524
16.

Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis.

Xu Y, Wu Y, Huang Q.

Arch Gynecol Obstet. 2017 Aug 2. doi: 10.1007/s00404-017-4480-z. [Epub ahead of print] Review.

PMID:
28770353
17.

Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes.

Griffin SJ, Leaver JK, Irving GJ.

Diabetologia. 2017 Aug 2. doi: 10.1007/s00125-017-4337-9. [Epub ahead of print] Review.

18.

Rationale for investigating metformin as a protectant against statin-associated muscle symptoms.

Elsaid O, Taylor B, Zaleski A, Panza G, Thompson PD.

J Clin Lipidol. 2017 Jul 8. pii: S1933-2874(17)30377-X. doi: 10.1016/j.jacl.2017.06.019. [Epub ahead of print] Review.

PMID:
28764958
19.

Safety, Efficacy, and Bioavailability of Fixed-Dose Combinations in Type 2 Diabetes Mellitus: A Systematic Updated Review.

Vijayakumar TM, Jayram J, Meghana Cheekireddy V, Himaja D, Dharma Teja Y, Narayanasamy D.

Curr Ther Res Clin Exp. 2017 Feb 2;84:4-9. doi: 10.1016/j.curtheres.2017.01.005. eCollection 2017. Review.

20.

Effects of metformin on endometrial cancer: Systematic review and meta-analysis.

Meireles CG, Pereira SA, Valadares LP, Rêgo DF, Simeoni LA, Guerra ENS, Lofrano-Porto A.

Gynecol Oncol. 2017 Jul 28. pii: S0090-8258(17)31136-8. doi: 10.1016/j.ygyno.2017.07.120. [Epub ahead of print] Review.

PMID:
28760367

Supplemental Content

Loading ...
Support Center